Sandbox Thymoma staging: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 42: Line 42:


{| style="border: 2px solid #696969;" align="center"
{| style="border: 2px solid #696969;" align="center"
|+ <SMALL>''Clinical Stage by Bergh (1978) and Wilkins (1979)''<ref name="Bergh-1978">{{Cite journal  | last1 = Bergh | first1 = NP. | last2 = Gatzinsky | first2 = P. | last3 = Larsson | first3 = S. | last4 = Lundin | first4 = P. | last5 = Ridell | first5 = B. | title = Tumors of the thymus and thymic region: I. Clinicopathological studies on thymomas. | journal = Ann Thorac Surg | volume = 25 | issue = 2 | pages = 91-8 | month = Feb | year = 1978 | doi =  | PMID = 626543 }}</ref><ref name="Wilkins-1979">{{Cite journal  | last1 = Wilkins | first1 = EW. | last2 = Castleman | first2 = B. | title = Thymoma: a continuing survey at the Massachusetts General Hospital. | journal = Ann Thorac Surg | volume = 28 | issue = 3 | pages = 252-6 | month = Sep | year = 1979 | doi =  | PMID = 485626 }}</ref></SMALL>
|+ <SMALL>''Clinical Staging by Bergh (1978) and Wilkins (1979)''<ref name="Bergh-1978">{{Cite journal  | last1 = Bergh | first1 = NP. | last2 = Gatzinsky | first2 = P. | last3 = Larsson | first3 = S. | last4 = Lundin | first4 = P. | last5 = Ridell | first5 = B. | title = Tumors of the thymus and thymic region: I. Clinicopathological studies on thymomas. | journal = Ann Thorac Surg | volume = 25 | issue = 2 | pages = 91-8 | month = Feb | year = 1978 | doi =  | PMID = 626543 }}</ref><ref name="Wilkins-1979">{{Cite journal  | last1 = Wilkins | first1 = EW. | last2 = Castleman | first2 = B. | title = Thymoma: a continuing survey at the Massachusetts General Hospital. | journal = Ann Thorac Surg | volume = 28 | issue = 3 | pages = 252-6 | month = Sep | year = 1979 | doi =  | PMID = 485626 }}</ref></SMALL>
! style="background: #F0F0F0; border: 0px solid #696969; padding: 0 5px; width: 100px;" | '''Author'''
! style="background: #F0F0F0; border: 0px solid #696969; padding: 0 5px; width: 100px;" | '''Author'''
! style="background: #F0F0F0; border: 0px solid #696969; padding: 0 5px; width: 15px;" | '''Stage'''
! style="background: #F0F0F0; border: 0px solid #696969; padding: 0 5px; width: 15px;" | '''Stage'''
Line 59: Line 59:
| align=center | '''III''' ||Invasive growth into the surrounding organs and/or intrathoracic metastases
| align=center | '''III''' ||Invasive growth into the surrounding organs and/or intrathoracic metastases
|}
|}


==TNM Staging (1999)==
==TNM Staging (1999)==

Revision as of 22:08, 28 February 2014

Thymoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Thymoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Sandbox Thymoma staging On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Sandbox Thymoma staging

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Sandbox Thymoma staging

CDC on Sandbox Thymoma staging

Sandbox Thymoma staging in the news

Blogs on Sandbox Thymoma staging

Directions to Hospitals Treating Thymoma

Risk calculators and risk factors for Sandbox Thymoma staging

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amr Marawan, M.D. [2]

Overview

Staging of thymic epithelial tumors was initially proposed by Bergh and his colleagues in 1978,[1] modified by Wilkins and Castleman in 1979,[2] and advanced by Masaoka et al. in 1981 and became widely adopted.[3][4] In 1999, World Health Organization (WHO) proposed

  • There is no universally accepted system; no AJCC staging exists.
  • Historically, a classifiaction system used both histological features and clinical behavior.
  • Masaoka staging is the clinically used staging system, although it may not be predictive for thymic carcinoma.
  • GETT staging is the surgical staging system, and may have better correlation with outcome.
  • A meta-analysis from UCLA suggests that evaluation of transcapsular extension (Stage I vs. Stage IIa) is of no clinical value, as they have same DFS and OS outcomes.

Historical Classification

  • Benign Thymoma (histologically and behaviorally benign)
  • Malignant Thymoma (invasive)
  • Type I - histologically benign, but behaving aggressively with local invasion
  • Type II ("thymic carcinoma") - histologically malignant, aggresive behavior


Masaoka Staging System (1981)[3]
Stage Description
I Macroscopically completely encapsulated and microscopically no capsular invasion
II1 Macroscopic invasion into surrounding fatty tissue or mediastinal pleura
II2 Microscopic invasion into capsule
III Macroscopic invasion into neighboring organ, ie, pericardium, great vessels, or lung
IVa Pleural or pericardial dissemination
IVb Lymphogenous or hematogenous metastasis


Clinical Staging by Bergh (1978) and Wilkins (1979)[1][2]
Author Stage Description
Bergh et al. I Intact capsule or growth within the capsule
II Pericapsular growth into the mediastinal fat tissue
III Invasive growth into the surrounding organs and/or intrathoracic metastases
Wilkins et al. I Intact capsule or growth within the capsule
II Pericapsular growth into the mediastinal fat tissue or adjacent pleura or pericardium
III Invasive growth into the surrounding organs and/or intrathoracic metastases

TNM Staging (1999)

[5]

Original Masaoka Staging (1991)

  • Stage I - Macroscopically and microscopically completely encapsulated
  • Stage II - Macroscopic invasion into surrounding fatty tissues or mediastinal pleura or microscopic invasion into the capsule
  • Stage III - Macroscopic invasion into adjacent organs or intrathoracic metastases
  • Stage IVA - Pleural or pericardial implants/dissemination
  • Stage IVB - Nodal or hematogenous metastases

GETT Staging

  • Stage IA - Encapsulated, completely resected.
  • Stage IB - Macroscopically completely resected but suspicion of mediastinal adhesions or potential capsular invasion at surgery.
  • Stage II - Invasive tumor, completely resected.
  • Stage IIIA - Invasive tumor, subtotal resection.
  • Stage IIIB - Invasive tumor, biopsy alone.
  • Stage IVa - Supraclav or pleural met.
  • Stage IVb - Distant metastases.[5]

References

  1. 1.0 1.1 Bergh, NP.; Gatzinsky, P.; Larsson, S.; Lundin, P.; Ridell, B. (1978). "Tumors of the thymus and thymic region: I. Clinicopathological studies on thymomas". Ann Thorac Surg. 25 (2): 91–8. PMID 626543. Unknown parameter |month= ignored (help)
  2. 2.0 2.1 Wilkins, EW.; Castleman, B. (1979). "Thymoma: a continuing survey at the Massachusetts General Hospital". Ann Thorac Surg. 28 (3): 252–6. PMID 485626. Unknown parameter |month= ignored (help)
  3. 3.0 3.1 Masaoka, A.; Monden, Y.; Nakahara, K.; Tanioka, T. (1981). "Follow-up study of thymomas with special reference to their clinical stages". Cancer. 48 (11): 2485–92. PMID 7296496. Unknown parameter |month= ignored (help)
  4. Kondo, K. (2005). "Invited commentary". Ann Thorac Surg. 80 (6): 2000–1. doi:10.1016/j.athoracsur.2005.08.053. PMID 16305832. Unknown parameter |month= ignored (help)
  5. 5.0 5.1 "Thymectomy and malignancy. [Eur J Cardiothorac Surg. 1994] - PubMed - NCBI".


Template:WikiDoc Sources